- The trend backdrop is active with a 25-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
4127
TWO
Week ended 14 Aug 2026
Weekly Investor Report
Tien Liang BioTech Co., Ltd. · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
83.30 TWD
-6.7%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 57.8% above the Trend Line and sits at 86.2% of its 52-week range. The latest completed week returned -6.7%, after a 1.2% four-week move. Near-term considerations: volume confirmation is below normal.
Setup score
59
out of 100
Latest Close
83.30 TWD
14 Aug 2026
1W Return
-6.7%
latest completed week
4W Return
1.2%
short-term follow-through
12W Return
32.4%
quarterly tape
Trend Breadth
48.1%
25 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- The latest week was a sharp negative move.
- Recent volatility is running well above the one-year baseline.
- Latest weekly return ranks in the weaker part of its sector group.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-6.7%
Latest completed week; four-week move 1.2%.
Indicator stack
71/63
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 57.8% above the Trend Line and sits at 86.2% of its 52-week range. The latest completed week returned -6.7%, after a 1.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.8212-week average 0.79
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.82Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 1.2% over four weeks, 32.4% over 12 weeks, and 144.6% over one year. The current trend has remained active for 25 consecutive weeks.
Performance by holding period
Active trend streak25 weeks
Active weeks in one year25
Trend breadth48.1%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.87Latest activity-pressure read.
Pressure change-29.0%Four-week change in activity pressure.
Leadership42.64Latest relative-leadership reading.
RS change-21.5%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment-
No current sentiment snapshot is stored.
Patient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-9.5%Distance below the 52-week high.
13-week volatility17.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
20 Mar
17 Apr
15 May
12 Jun
10 Jul
14 Aug
Weeks higher11 of 2614 weeks finished lower.
Best week+60.9%Week of 22 May.
Worst week-6.7%Week of 14 Aug.
Latest week-6.7%Week of 14 Aug.
Shape of recent returns
Strong gains6
Modest gains5
Flat weeks1
Modest losses11
Sharp losses3
Recent vol17.4%13-week weekly-return volatility.
Base vol10.0%52-week weekly-return volatility.
Up/down split20/30Count of positive and negative weeks in the 52-week window.
Average skew9.0% / -2.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank39 / 100
Group average0.1%
Trend breadth34.0%
Trend34.0%active weekly trend signals
MD60.0%positive activity pressure
RS9.0%positive relative leadership
Four-week leaders
IndustryTW Drug Manufacturers - Specialty & Generic
4-week rank13 / 42
Group average-0.1%
Trend breadth21.4%
Trend21.4%active weekly trend signals
MD45.2%positive activity pressure
RS4.8%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape59/100
Trend, activity pressure, participation, and risk combine to a 59/100 tape read.
Indicator analysis88/100Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.
Activity pressure 0.82; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100No sentiment snapshot is stored yet.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 14 Aug 2026 | 83.30 TWD | -6.7% | 52.80 TWD | 34.63 TWD | 0.87 | 42.64 | 1.7M | On |
| 7 Aug 2026 | 89.30 TWD | 21.0% | 51.02 TWD | 34.19 TWD | 0.98 | 59.36 | 1.8M | On |
| 31 Jul 2026 | 73.80 TWD | -6.5% | 49.06 TWD | 33.71 TWD | 1.07 | 36.19 | 1.1M | On |
| 24 Jul 2026 | 78.90 TWD | -4.1% | 47.59 TWD | 33.33 TWD | 1.20 | 44.13 | 1.5M | On |
| 17 Jul 2026 | 82.30 TWD | 11.2% | 45.98 TWD | 32.92 TWD | 1.22 | 54.29 | 2.6M | On |
| 10 Jul 2026 | 74.00 TWD | 6.0% | 44.24 TWD | 32.48 TWD | 1.25 | 31.26 | 4.3M | On |
| 3 Jul 2026 | 69.80 TWD | 8.2% | 42.78 TWD | 32.11 TWD | 1.29 | 20.07 | 1.0M | On |
| 26 Jun 2026 | 64.50 TWD | -3.9% | 41.46 TWD | 31.75 TWD | 1.41 | 16.20 | 1.3M | On |
| 19 Jun 2026 | 67.10 TWD | -1.3% | 40.34 TWD | 31.44 TWD | 1.60 | 15.57 | 2.0M | On |
| 12 Jun 2026 | 68.00 TWD | -1.3% | 39.13 TWD | 31.10 TWD | 1.69 | 22.77 | 1.9M | On |
| 5 Jun 2026 | 68.90 TWD | -0.1% | 37.93 TWD | 30.76 TWD | 1.44 | 21.67 | 1.5M | On |
| 29 May 2026 | 69.00 TWD | 9.7% | 36.70 TWD | 30.42 TWD | 1.14 | 22.48 | 5.2M | On |
| 22 May 2026 | 62.90 TWD | 60.9% | 35.49 TWD | 30.07 TWD | 0.73 | 17.83 | 5.7M | On |
| 15 May 2026 | 39.10 TWD | -1.8% | 34.52 TWD | 29.76 TWD | 0.39 | -25.09 | 8.3M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.